Pilot Clinical Study Testing Tiger Milk Mushroom Gel (Lignosus Rhinocerus TM02) for Treating Mouth Ulcers
Status:
COMPLETED
Trial end date:
2024-02-23
Target enrollment:
Participant gender:
Summary
This is a pilot clinical trial study to investigate the wound healing capability of a TM02 water extract formulation in patient with minor oral ulcers (2 - 5 mm in size). The sclerotium of L. rhinocerus is traditionally used as a health tonic or treatment regime for asthma, bronchitis, various cancer ailments as well as discomforts caused by fright, fever, cough, vomiting, and injury. Further on to that, this mushroom has also been traditionally used by the local Malay and Chinese communities to treat wounds, although it is yet to be scientifically validated. Its sclerotia are being consumed in the form of decoction, in a betel quid, and other preparation method where the sclerotium is pounded with raw rice, infused, and subsequently taken as a drink. There is also a practice of biting/chewing of the sclerotium by local indigenous communities during their journeys in the wild.